The 3' to 5' exoribonuclease DIS3: From structure and mechanisms to biological functions and role in human disease

Biomolecules

Volumn 5, Issue 3, 2015, Pages 1515-1539

  Robinson, Sophie R ^a   Oliver, Antony W ^b   Chevassut, Timothy J ^a   Newbury, Sarah F ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

DIS3; Exoribonuclease; Multiple myeloma; RNA stability

Indexed keywords

EXORIBONUCLEASE; EXORIBONUCLEASE DIS3; UNCLASSIFIED DRUG; DIS3 PROTEIN, HUMAN; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX;

BIOLOGICAL FUNCTIONS; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHROMOSOME TRANSLOCATION; ENZYME MECHANISM; ENZYME STRUCTURE; GENE EXPRESSION; HUMAN; MULTIPLE MYELOMA; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; REVIEW; SOMATIC HYPERMUTATION; ANIMAL; CHEMISTRY; CONSERVED SEQUENCE; DISEASES; GENETICS; METABOLISM; PROTEIN TRANSPORT;

SCHIZOSACCHAROMYCES POMBE;

ANIMALS; CONSERVED SEQUENCE; DISEASE; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX; HUMANS; PROTEIN TRANSPORT;

EID: 85012054078     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5031515     Document Type: Review

References (113)

1. Cairrao, F.; Arraiano, C; Newbury, S. Drosophila gene tazman, an orthologue of the yeast exosome component Rrp44p/Dis3, is differentially expressed during development. Dev. Dyn. 2005, 232, 733-737.
2. Jones, C.I.; Zabolotskaya, M.V.; Newbury, S.F. The 5'-3' exoribonuclease XRNl/Pacman and its functions in cellular processes and development. Wiley Interdiscip. Rev. RNA 2012, 3, 455-468.
3. Waldron, J.A.; Jones, C.I.; Towler, B.P.; Pashler, A.L.; Grima, D.P.; Hebbes, S.; Crossman, S.H.; Zabolotskaya, M.V.; Newbury, S.F. Xrnl/Pacman affects apoptosis and regulates expression of hid and reaper. Biol. Open 2015, doi:10.1242/bio.201410199.
4. Jones, C.I.; Grima, D.P.; Waldron, J.A.; Jones, S.; Parker, H.N.; Newbury, S.F. The 5'-3' exoribonuclease Pacman (Xrn1) regulates expression of the heat shock protein Hsp67Bc and the microRNA miR-277-3p in Drosophila wing imaginal discs. RNA Biol. 2013, 10, 1345-1355.
5. Wasmuth, E.V.; Lima, C.D. Exo-and endoribonucleolytic activities of yeast cytoplasmic and nuclear RNA exosomes are dependent on the noncatalytic core and central channel. Mol. Cell 2012, 48, 133-144.
6. Bousquet-Antonelli, C.; Presutti, C.; Tollervey, D. Identification of a regulated pathway for nuclear pre-mRNA turnover. Cell 2000, 102, 765-775.
7. Milligan, L.; Torchet, C.; Allmang, C.; Shipman, T.; Tollervey, D. A nuclear surveillance pathway for mRNAs with defective polyadenylation. Mol. Cell. Biol. 2005, 25, 9996-10004.
8. Mukherjee, D.; Gao, M.; O'Connor, J.P.; Raijmakers, R.; Pruijn, G.; Lutz, C.S.; Wilusz, J. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J. 2002, 21, 165-174.
9. Chen, C.Y.; Gherzi, R.; Ong, S.E.; Chan, E.L.; Raijmakers, R.; Pruijn, G.J.; Stoecklin, G.; Moroni, C.; Mann, M.; Karin, M. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 2001, 107, 451-464.
10. Allmang, C.; Kufel, J.; Chanfreau, G.; Mitchell, P.; Petfalski, E.; Tollervey, D. Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J. 1999, 18, 5399-5410.
11. Mitchell, P.; Petfalski, E.; Shevchenko, A.; Mann, M.; Tollervey, D. The exosome: A conserved eukaryotic RNA processing complex containing multiple 3'-5' exoribonucleases. Cell 1997, 91, 457-466.
12. Ohkura, H.; Adachi, Y.; Kinoshita, N.; Niwa, O.; Toda, T.; Yanagida, M. Cold-sensitive and caffeine-supersensitive mutants of the Schizosaccharomyces pombe dis genes implicated in sister chromatid separation during mitosis. EMBO J. 1988, 7, 1465-1473.
13. Kinoshita, N.; Goebl, M.; Yanagida, M. The fission yeast Dis3+ gene encodes a 110-kDa essential protein implicated in mitotic control. Mol. Cell. Biol. 1991, 11, 5839-5847.
14. Noguchi, E.; Hayashi, N.; Azuma, Y.; Seki, T.; Nakamura, M.; Nakashima, N.; Yanagida, M.; He, X.; Mueller, U.; Sazer, S., et al. Dis3, implicated in mitotic control, binds directly to Ran and enhances the GEF activity of RCC1. EMBO J. 1996, 15, 5595-5605.
15. Smith, S.B.; Kiss, D.L.; Turk, E.; Tartakoff, A.M.; Andrulis, E.D. Pronounced and extensive microtubule defects in a Saccharomyces cerevisiae DIS3 mutant. Yeast 2011, 28, 755-769.
16. Murakami, H.; Goto, D.B.; Toda, T.; Chen, E.S.; Grewal, S.I.; Martienssen, R.A.; Yanagida, M. Ribonuclease activity of Dis3 is required for mitotic progression and provides a possible link between heterochromatin and kinetochore function. PLoS ONE 2007, 2, e317.
17. Basu, U.; Meng, F.L.; Keim, C; Grinstein, V.; Pefanis, E.; Eccleston, J.; Zhang, T.; Myers, D.; Wasserman, C.R.; Wesemann, D.R., et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 2011, 144, 353-363.
18. Lim, J.; Kuroki, T.; Ozaki, K.; Kohsaki, H.; Yamori, T.; Tsuruo, T.; Nakamori, S.; Imaoka, S.; Endo, M.; Nakamura, Y. Isolation of murine and human homologues of the fission-yeast Dis3+ gene encoding a mitotic-control protein and its overexpression in cancer cells with progressive phenotype. Cancer Res. 1997, 57, 921-925.
19. Liang, L.; Qu, L.; Ding, Y. Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials. Cancer Investig. 2007, 25, 427-434.
20. De Groen, F.L.; Krijgsman, O.; Tijssen, M.; Vriend, L.E.; Ylstra, B.; Hooijberg, E.; Meijer, G.A.; Steenbergen, R.D.; Carvalho, B. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression. Genes Chromosomes Cancer 2014, 53, 339-348.
21. Rozenblum, E.; Vahteristo, P.; Sandberg, T.; Bergthorsson, J.T.; Syrjakoski, K.; Weaver, D.; Haraldsson, K.; Johannsdottir, H.K.; Vehmanen, P.; Nigam, S., et al. A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: Identification and characterization of candidate genes. Hum. Genet. 2002, 110, 111-121.
22. Ng, D.; Toure, O.; Wei, M.H.; Arthur, D.C.; Abbasi, F.; Fontaine, L.; Marti, G.E.; Fraumeni, J.F.; Goldin, L.R.; Caporaso, N., et al. Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia. Blood 2007, 109, 916-925.
23. Rose, A.E.; Poliseno, L.; Wang, J.; Clark, M.; Pearlman, A.; Wang, G.; Vega Y, Saenz Miera, E.C.; Medicherla, R.; Christos, P.J.; Shapiro, R., et al. Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression. Cancer Res. 2011, 71, 2561-2571.
24. Liu, W.; Peng, Y.; Tobin, D.J. A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. Peer J. 2013, 1, e49.
25. Lohr, J.G.; Stojanov, P.; Carter, S.L.; Cruz-Gordillo, P.; Lawrence, M.S.; Auclair, D.; Sougnez, C.; Knoechel, B.; Gould, J.; Saksena, G., et al. Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy. Cancer Cell 2014, 25, 91-101.
26. Chapman, M.A.; Lawrence, M.S.; Keats, J.J.; Cibulskis, K.; Sougnez, C.; Schinzel, A.C.; Harview, C.L.; Brunet, J.P.; Ahmann, G.J.; Adli, M., et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011, 471, 467-472.
27. Walker, B.A.; Wardell, C.P.; Melchor, L.; Hulkki, S.; Potter, N.E.; Johnson, D.C.; Fenwick, K.; Kozarewa, I.; Gonzalez, D.; Lord, C.J., et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood 2012, 120, 1077-1086.
28. Weißbach, S.; Langer, C.; Puppe, B.; Nedeva, T.; Bach, E.; Kull, M.; Bargou, R.; Einsele, H.; Rosenwald, A.; Knop, S., et al. The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma. Br. J. Haematol. 2015, 169, 57-70.
29. Leich, E.; Weißbach, S.; Klein, H.U.; Grieb, T.; Pischimarov, J.; Stühmer, T.; Chatterjee, M.; Steinbrunn, T.; Langer, C.; Eilers, M., et al. Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion-and receptor tyrosine kinase signaling molecules. Blood Cancer J. 2013, 3, e102.
30. Zuo, Y.; Deutscher, M.P. Exoribonuclease superfamilies: Structural analysis and phylogenetic distribution. Nucleic Acids Res. 2001, 29, 1017-1026.
31. Tomecki, R.; Kristiansen, M.S.; Lykke-Andersen, S.; Chlebowski, A.; Larsen, K.M.; Szczesny, R.J.; Drazkowska, K.; Pastula, A.; Andersen, J.S.; Stepien, P.P., et al. The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L. EMBO J. 2010, 29, 2342-2357.
32. Frazäo, C.; McVey, C.E.; Amblar, M.; Barbas, A.; Vonrhein, C.; Arraiano, C.M.; Carrondo, M.A. Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex. Nature 2006, 443, 110-114.
33. Lebreton, A.; Tomecki, R.; Dziembowski, A.; Séraphin, B. Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature 2008, 456, 993-996.
34. Schaeffer, D.; Reis, F.P.; Johnson, S.J.; Arraiano, C.M.; van Hoof, A. The CR3 motif of Rrp44p is important for interaction with the core exosome and exosome function. Nucleic Acids Res. 2012, 40, 9298-9307.
35. Staals, R.H.; Bronkhorst, A.W.; Schilders, G.; Slomovic, S.; Schuster, G.; Heck, A.J.; Raijmakers, R.; Pruijn, G.J. Dis3-like 1: A novel exoribonuclease associated with the human exosome. EMBO J. 2010, 29, 2358-2367.
36. Zhang, W.; Murphy, C.; Sieburth, L.E. Conserved RNaseII domain protein functions in cytoplasmic mRNA decay and suppresses Arabidopsis decapping mutant phenotypes. Proc. Natl. Acad. Sci. USA 2010, 107, 15981-15985.
37. Kumakura, N.; Otsuki, H.; Tsuzuki, M.; Takeda, A.; Watanabe, Y. Arabidopsis AtRRP44A is the functional homolog of Rrp44/Dis3, an exosome component, is essential for viability and is required for RNA processing and degradation. PLoS ONE 2013, 8, e79219.
38. Chang, H.M.; Triboulet, R.; Thornton, J.E.; Gregory, R.I. A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway. Nature 2013, 497, 244-248.
39. Schaeffer, D.; Tsanova, B.; Barbas, A.; Reis, F.P.; Dastidar, E.G.; Sanchez-Rotunno, M.; Arraiano, C.M.; van Hoof, A. The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities. Nat. Struct. Mol. Biol. 2009, 16, 56-62.
40. Lorentzen, E.; Basquin, J.; Tomecki, R.; Dziembowski, A.; Conti, E. Structure of the active subunit of the yeast exosome core, Rrp44: Diverse modes of substrate recruitment in the RNase II nuclease family. Mol. Cell 2008, 29, 717-728.
41. Dziembowski, A.; Lorentzen, E.; Conti, E.; Seraphin, B. A single subunit, Dis3, is essentially responsible for yeast exosome core activity. Nat. Struct. Mol. Biol. 2007, 14, 15-22.
42. Liu, Q.; Greimann, J.C.; Lima, C.D. Reconstitution, activities, and structure of the eukaryotic RNA exosome. Cell 2006, 127, 1223-1237.
43. Lee, G.; Bratkowski, M.A.; Ding, F.; Ke, A.; Ha, T. Elastic coupling between RNA degradation and unwinding by an exoribonuclease. Science 2012, 336, 1726-1729.
44. Makino, D.L.; Baumgartner, M.; Conti, E. Crystal structure of an RNA-bound 11-subunit eukaryotic exosome complex. Nature 2013, 495, 70-75.
45. Graham, A.C.; Davis, S.M.; Andrulis, E.D. Interdependent nucleocytoplasmic trafficking and interactions of Dis3 with Rrp6, the core exosome and importin-alpha3. Traffic 2009, 10, 499-513.
46. Symmons, M.F.; Luisi, B.F. Through ancient rings thread programming strings. Structure 2009, 17, 1429-1431.
47. Schneider, C.; Leung, E.; Brown, J.; Tollervey, D. The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome. Nucleic Acids Res. 2009, 37, 1127-1140.
48. Drazkowska, K.; Tomecki, R.; Stodus, K.; Kowalska, K.; Czarnocki-Cieciura, M.; Dziembowski, A. The RNA exosome complex central channel controls both exonuclease and endonuclease Dis3 activities in vivo and in vitro. Nucleic Acids Res. 2013, 41, 3845-3858.
49. Halbach, F.; Reichelt, P.; Rode, M.; Conti, E. The yeast ski complex: Crystal structure and RNA channeling to the exosome complex. Cell 2013, 154, 814-826.
50. LaCava, J.; Houseley, J.; Saveanu, C.; Petfalski, E.; Thompson, E.; Jacquier, A.; Tollervey, D. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell 2005, 121, 713-724.
51. Schneider, C.; Kudla, G.; Wlotzka, W.; Tuck, A.; Tollervey, D. Transcriptome-wide analysis of exosome targets. Mol. Cell 2012, 48, 422-433.
52. Mitchell, P. Exosome substrate targeting: The long and short of it. Biochem. Soc. Trans. 2014, 42, 1129-1134.
53. Briggs, M.W.; Burkard, K.T.; Butler, J.S. Rrp6p, the yeast homologue of the human PM-Scl 100-kDa autoantigen, is essential for efficient 5.8 S rRNA 3' end formation. J. Biol. Chem. 1998, 273, 13255-13263.
54. Graham, A.C.; Kiss, D.L.; Andrulis, E.D. Differential distribution of exosome subunits at the nuclear lamina and in cytoplasmic foci. Mol. Biol. Cell 2006, 17, 1399-1409.
55. Shiomi, T.; Fukushima, K.; Suzuki, N.; Nakashima, N.; Noguchi, E.; Nishimoto, T. Human Dis3p, which binds to either GTP-or GDP-Ran, complements Saccharomyces cerevisiae Dis3. J. Biochem. 1998, 123, 883-890.
56. Mamolen, M.; Smith, A.; Andrulis, E.D. Drosophila melanogaster Dis3 N-terminal domains are required for ribonuclease activities, nuclear localization and exosome interactions. Nucleic Acids Res. 2010, 38, 5507-5517.
57. Chlebowski, A.; Lubas, M.; Jensen, T.H.; Dziembowski, A. RNA decay machines: The exosome. Biochim. Biophys. Acta 2013, 1829, 552-560.
58. Garneau, N.L.; Wilusz, J.; Wilusz, C.J. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 2007, 8, 113-126.
59. Newbury, S.F. Control of mRNA stability in eukaryotes. Biochem. Soc. Trans. 2006, 34, 30-34.
60. Andrulis, E.D.; Werner, J.; Nazarian, A.; Erdjument-Bromage, H.; Tempst, P.; Lis, J.T. The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila. Nature 2002, 420, 837-841.
61. Lejeune, F.; Li, X.; Maquat, L.E. Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. Mol. Cell 2003, 12, 675-687.
62. Frischmeyer, P.A.; van Hoof, A.; O'Donnell, K.; Guerrerio, A.L.; Parker, R.; Dietz, H.C. An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 2002, 295, 2258-2261.
63. Van Hoof, A.; Frischmeyer, P.A.; Dietz, H.C.; Parker, R. Exosome-mediated recognition and degradation of mRNAs lacking a termination codon. Science 2002, 295, 2262-2264.
64. Doma, M.K.; Parker, R. Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation. Nature 2006, 440, 561-564.
65. Kashima, I.; Yamashita, A.; Izumi, N.; Kataoka, N.; Morishita, R.; Hoshino, S.; Ohno, M.; Dreyfuss, G.; Ohno, S. Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. Genes Dev. 2006, 20, 355-367.
66. Kiss, D.L.; Andrulis, E.D. Genome-wide analysis reveals distinct substrate specificities of Rrp6, Dis3, and core exosome subunits. RNA 2010, 16, 781-791.
67. Bakheet, T.; Williams, B.R.; Khabar, K.S. ARED 3.0: The large and diverse AU-rich transcriptome. Nucleic Acids Res. 2006, 34, D111-D114.
68. Halees, A.S.; Hitti, E.; Al-Saif, M.; Mahmoud, L.; Vlasova-St Louis, I.A.; Beisang, D.J.; Bohjanen, P.R.; Khabar, K. Global assessment of GU-rich regulatory content and function in the human transcriptome. RNA Biol. 2011, 8, 681-691.
69. Huntzinger, E.; Izaurralde, E. Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011, 12, 99-110.
70. Rehwinkel, J.; Behm-Ansmant, I.; Gatfield, D.; Izaurralde, E. A crucial role for GW182 and the DCP1: DCP2 decapping complex in miRNA-mediated gene silencing. RNA 2005, 11, 1640-1647.
71. Butler, J.S. The yin and yang of the exosome. Trends Cell Biol. 2002, 12, 90-96.
72. Mitchell, P.; Petfalski, E.; Tollervey, D. The 3' end of yeast 5.8 S rRNA is generated by an exonuclease processing mechanism. Genes Dev. 1996, 10, 502-513.
73. Kadaba, S.; Krueger, A.; Trice, T.; Krecic, A.M.; Hinnebusch, A.G.; Anderson, J. Nuclear surveillance and degradation of hypomodified initiator tRNAMet in S. cerevisiae. Genes Dev. 2004, 18, 1227-1240.
74. Schneider, C.; Anderson, J.T.; Tollervey, D. The exosome subunit Rrp44 plays a direct role in RNA substrate recognition. Mol. Cell 2007, 27, 324-331.
75. Gudipati, R.K.; Xu, Z.; Lebreton, A.; Séraphin, B.; Steinmetz, L.M.; Jacquier, A.; Libri, D. Extensive degradation of RNA precursors by the exosome in wild-type cells. Mol. Cell 2012, 48, 409-421.
76. Hata, A.; Lieberman, J. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci. Signal. 2015, doi:10.1126/scisignal.2005825.
77. Krol, J.; Loedige, I.; Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11, 597-610.
78. Triboulet, R.; Chang, H.M.; Lapierre, R.J.; Gregory, R.I. Post-transcriptional control of DGCR8 expression by the Microprocessor. RNA 2009, 15, 1005-1011.
79. Han, J.; Pedersen, J.S.; Kwon, S.C.; Belair, C.D.; Kim, Y.K.; Yeom, K.H.; Yang, W.Y.; Haussler, D.; Blelloch, R.; Kim, V.N. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 2009, 136, 75-84.
80. Towler, B.P.; Jones, C.I.; Viegas, S.C.; Apura, P.; Waldron, J.A.; Smalley, S.K.; Arraiano, C.M.; Newbury, S.F. The 3'-5' exoribonuclease Dis3 regulates the expression of specific microRNAs in Drosophila wing imaginal discs. RNA Biol. 2015, doi:10.1080/15476286.2015.1040978.
81. Flynt, A.S.; Greimann, J.C.; Chung, W.J.; Lima, C.D.; Lai, E.C. MicroRNA biogenesis via splicing and exosome-mediated trimming in Drosophila. Mol. Cell 2010, 38, 900-907.
82. Liu, X.; Zheng, Q.; Vrettos, N.; Maragkakis, M.; Alexiou, P.; Gregory, B.D.; Mourelatos, Z. A MicroRNA precursor surveillance system in quality control of MicroRNA synthesis. Mol. Cell 2014, 55, 868-879.
83. Preker, P.; Nielsen, J.; Kammler, S.; Lykke-Andersen, S.; Christensen, M.S.; Mapendano, C.K.; Schierup, M.H.; Jensen, T.H. RNA exosome depletion reveals transcription upstream of active human promoters. Science 2008, 322, 1851-1854.
84. Preker, P.; Almvig, K.; Christensen, M.S.; Valen, E.; Mapendano, C.K.; Sandelin, A.; Jensen, T.H. PROMoter uPstream Transcripts share characteristics with mRNAs and are produced upstream of all three major types of mammalian promoters. Nucleic Acids Res. 2011, 39, 7179-7193.
85. Tomecki, R.; Drazkowska, K.; Kucinski, I.; Stodus, K.; Szczesny, R.J.; Gruchota, J.; Owczarek, E.P.; Kalisiak, K.; Dziembowski, A. Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism and suggest hDIS3 PIN domain as a potential drug target. Nucleic Acids Res. 2014, 42, 1270-1290.
86. Desai, A.; Hyman, A. Microtubule cytoskeleton: No longer an also Ran. Curr. Biol. 1999, 9, R704-R707.
87. Sazer, S.; Dasso, M. The ran decathlon: Multiple roles of Ran. J. Cell Sci. 2000, 113, 1111-1118.
88. Carazo-Salas, R.E.; Guarguaglini, G.; Gruss, O.J.; Segref, A.; Karsenti, E.; Mattaj, I.W. Generation of GTP-bound Ran by RCC1 is required for chromatin-induced mitotic spindle formation. Nature 1999, 400, 178-181.
89. Clarke, P.R.; Zhang, C. Spatial and temporal coordination of mitosis by Ran GTPase. Nat. Rev. Mol. Cell Biol. 2008, 9, 464-477.
90. Arnaoutov, A.; Dasso, M. The Ran GTPase regulates kinetochore function. Dev. Cell 2003, 5, 99-111.
91. Suzuki, N.; Noguchi, E.; Nakashima, N.; Oki, M.; Ohba, T.; Tartakoff, A.; Ohishi, M.; Nishimoto, T. The Saccharomyces cerevisiae small GTPase, Gsp1p/Ran, is involved in 3' processing of 7 S-to-5.8 S rRNA and in degradation of the excised 5'-A0 fragment of 35 S pre-rRNA, both of which are carried out by the exosome. Genetics 2001, 158, 613-625.
92. Maiato, H.; DeLuca, J.; Salmon, E.D.; Earnshaw, W.C. The dynamic kinetochore-microtubule interface. J. Cell Sci. 2004, 117, 5461-5477.
93. Kadowaki, T.; Chen, S.; Hitomi, M.; Jacobs, E.; Kumagai, C.; Liang, S.; Schneiter, R.; Singleton, D.; Wisniewska, J.; Tartakoff, A.M. Isolation and characterization of Saccharomyces cerevisiae mRNA transport-defective (mtr) mutants. J. Cell Biol. 1994, 126, 649-659.
94. Vasiljeva, L.; Kim, M.; Terzi, N.; Soares, L.M.; Buratowski, S. Transcription termination and RNA degradation contribute to silencing of RNA polymerase II transcription within heterochromatin. Mol. Cell 2008, 29, 313-323.
95. Wang, S.W.; Stevenson, A.L.; Kearsey, S.E.; Watt, S.; Bähler, J. Global role for polyadenylation-assisted nuclear RNA degradation in posttranscriptional gene silencing. Mol. Cell Biol. 2008, 28, 656-665.
96. Grewal, S.I.; Elgin, S.C. Heterochromatin: New possibilities for the inheritance of structure. Curr. Opin. Genet. Dev. 2002, 12, 178-187.
97. Buhler, M.; Haas, W.; Gygi, S.P.; Moazed, D. RNAi-dependent and α-independent RNA turnover mechanisms contribute to heterochromatic gene silencing. Cell 2007, 129, 707-721.
98. Camps, J.; Pitt, J.J.; Emons, G.; Hummon, A.B.; Case, C.M.; Grade, M.; Jones, T.L.; Nguyen, Q.T.; Ghadimi, B.M.; Beissbarth, T., et al. Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/ß-catenin pathway in colorectal cancer. Cancer Res. 2013, 73, 2003-2013.
99. Ding, L.; Ley, T.J.; Larson, D.E.; Miller, C.A.; Koboldt, D.C.; Welch, J.S.; Ritchey, J.K.; Young, M.A.; Lamprecht, T.; McLellan, M.D., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481, 506-510.
100. Welch, J.S.; Ley, T.J.; Link, D.C.; Miller, C.A.; Larson, D.E.; Koboldt, D.C.; Wartman, L.D.; Lamprecht, T.L.; Liu, F.; Xia, J., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012, 150, 264-278.
101. Kyle, R.A.; Rajkumar, S.V. Multiple myeloma. N. Engl. J. Med. 2004, 351, 1860-1873.
102. Laubach, J.; Richardson, P.; Anderson, K. Multiple myeloma. Annu. Rev. Med. 2011, 62, 249-264.
103. Kelley, L.A.; Sternberg, M.J. Protein structure prediction on the Web: A case study using the Phyre server. Nat. Protoc. 2009, 4, 363-371.
104. Shlush, L.I.; Hershkovitz, D. Clonal evolution models of tumor heterogeneity. Am. Soc. Clin. Oncol. Educ. Book 2015, 35, e662-e665.
105. Greaves, M.; Maley, C.C. Clonal evolution in cancer. Nature 2012, 481, 306-313.
106. Melchor, L.; Brioli, A.; Wardell, C.P.; Murison, A.; Potter, N.E.; Kaiser, M.F.; Fryer, R.A.; Johnson, D.C.; Begum, D.B.; Hulkki Wilson, S., et al. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia 2014, 28, 1705-1715.
107. Morgan, G.J.; Walker, B.A.; Davies, F.E. The genetic architecture of multiple myeloma. Nat. Rev. Cancer 2012, 12, 335-348.
108. Boyd, K.D.; Pawlyn, C.; Morgan, G.J.; Davies, F.E. Understanding the molecular biology of myeloma and its therapeutic implications. Expert Rev. Hematol. 2012, 5, 603-617.
109. Bianchi, G.; Ghobrial, I.M. Biological and clinical implications of clonal heterogeneity and clonal evolution in multiple myeloma. Curr. Cancer Ther. Rev. 2014, 10, 70-79.
110. Kuchta, K.; Knizewski, L.; Wyrwicz, L.S.; Rychlewski, L.; Ginalski, K. Comprehensive classification of nucleotidyltransferase fold proteins: Identification of novel families and their representatives in human. Nucleic Acids Res. 2009, 37, 7701-7714.
111. Meng, T. The Molecular Cloning and Characterization of Fam46c RNA Stability Factor, Ph.D. Thesis, Harvard University, Cambridge, MA, USA, 2010.
112. Drach, J.; Schuster, J.; Nowotny, H.; Angerler, J.; Rosenthal, F.; Fiegl, M.; Rothermundt, C.; Gsur, A.; Jäger, U.; Heinz, R. Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res. 1995, 55, 3854-3859.
113. Diaz-Rodriguez, E.; Alvarez-Fernandez, S.; Chen, X.; Paiva, B.; Lopez-Perez, R.; Garcia-Hernandez, J.L.; San Miguel, J.F.; Pandiella, A. Deficient spindle assembly checkpoint in multiple myeloma. PLoS ONE 2011, 6, e27583.